Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
AbbVie (NYSE:ABBV) Trading 2% Higher Following Analyst Upgrade
AbbVie (ABBV) One Off US$5.0b Loss Tests Bullish High P/E Valuation Narratives
Prime Capital Investment Advisors LLC Buys 3,759 Shares of AbbVie Inc. $ABBV - Markets Daily
Machina Capital S.A.S. Has $356,000 Holdings in AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Issues Quarterly Earnings Results - Stock Observer
Top Medical Stocks To Add to Your Watchlist - February 4th - Stock Observer
AbbVie's Prognosis: The February Dip Looks Like a Buy Signal | Investing.com
Best Pharmaceutical Stocks To Watch Today - February 5th - Stock Observer
AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript
AbbVie Inc. $ABBV Shares Purchased by Howe & Rusling Inc. - Markets Daily
AbbVie Inc. $ABBV Shares Bought by ABN AMRO Bank N.V.
AbbVie Inc. $ABBV Stock Position Reduced by Homestead Advisers Corp
HORAN Wealth LLC Boosts Stock Holdings in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by Bessemer Group Inc.
AbbVie (NYSE:ABBV) Price Target Raised to $270.00 - Stock Observer
AbbVie Earnings: Skyrizi Holds Steady Share Despite Competition | Morningstar Canada
AbbVie Q4 Earnings Call Highlights | MarketBeat
Triglav Investments D.O.O. Purchases 28,700 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie (NYSE:ABBV) Shares Down 3.8% - Here's What Happened
AbbVie Inc (ABBV) Q4 2025 Earnings Call Highlights: Record Revenues and Strategic Growth Plans
AbbVie (NYSE:ABBV) Issues Q1 2026 Earnings Guidance - Stock Observer
AbbVie (NYSE:ABBV) Announces Earnings Results, Misses Estimates By $0.66 EPS
AbbVie (NYSE:ABBV) Shares Gap Down After Earnings Miss
AbbVie (ABBV) Stock: Why Shares Are Falling Despite Earnings Beat and Strong 2026 Guidance
AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial R
AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs
AlphaQuest LLC Trims Stock Position in AbbVie Inc. $ABBV
AbbVie (NYSE:ABBV) Issues FY 2026 Earnings Guidance - Daily Political
Savant Capital LLC Has $42.96 Million Holdings in AbbVie Inc. $ABBV
AbbVie Guides FY26 Adj. EPS Above Estimates; Q4 Results Top Estimates
AbbVie Q4 25 Earnings Conference Call At 9:00 AM ET
AbbVie News | Markets Insider
Envestnet Asset Management Inc. Reduces Position in AbbVie Inc. $ABBV - Daily Political
Savant Capital LLC Purchases 13,839 Shares of AbbVie Inc. $ABBV - Daily Political
Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial
Pharmaceutical Stocks To Watch Now - February 3rd - Markets Daily
Jim Cramer Says "I Like AstraZeneca Very Much"
AbbVie Targets Post Humira Growth With Cell Therapy And RINVOQ Expansion
Pettee Investors Inc. Trims Stake in AbbVie Inc. $ABBV
What Does Wall Street Think About AbbVie Inc. (ABBV)?
AbbVie Inc. $ABBV Shares Sold by Sollinda Capital Management LLC - Stock Observer
AbbVie Inc. $ABBV Shares Purchased by Jones Financial Companies Lllp - Stock Observer
Elm Partners Management LLC Buys 2,609 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie (ABBV) Q4 Earnings: What To Expect
AbbVie Inc. (ABBV): A Bull Case Theory
Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study
AbbVie (NYSE:ABBV) Trading 1.2% Higher - Time to Buy?
AbbVie's Shift Beyond Humira With Skyrizi and Rinvoq Might Change The Case For Investing In AbbVie (ABBV)
Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily
Guerra Advisors Inc Increases Stake in AbbVie Inc. $ABBV
AbbVie Inc. $ABBV Shares Sold by AGF Management Ltd.
United Community Bank Has $2.39 Million Holdings in AbbVie Inc. $ABBV - Markets Daily
United Community Bank Has $2.39 Million Stake in AbbVie Inc. $ABBV - Stock Observer
Medical Stocks To Keep An Eye On - February 1st - Markets Daily
AbbVie's US$100b Drug Pricing Pact Reshapes Growth And Policy Outlook
Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily
AbbVie Inc. $ABBV Shares Bought by Donaldson Capital Management LLC - Markets Daily
Government Exempts Customs Duty on 17 Critical Cancer Drugs to Alleviate Patient Costs, ETPharma
AbbVie Inc. $ABBV Shares Sold by Transcend Capital Advisors LLC
AbbVie Inc. $ABBV Shares Purchased by Thrivent Financial for Lutherans - Markets Daily
AbbVie Inc. $ABBV Shares Bought by Atle Fund Management AB
AbbVie Inc. $ABBV is Donaldson Capital Management LLC's 6th Largest Position - Stock Observer
Thrivent Financial for Lutherans Acquires 34,384 Shares of AbbVie Inc. $ABBV - Stock Observer
Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma
AbbVie Inc. $ABBV Stake Decreased by Keybank National Association OH
National Pension Service Raises Stock Position in AbbVie Inc. $ABBV
AbbVie's US$100b Pledge Raises Questions On Value, Margins And Debt
L.M. Kohn & Company Decreases Stock Position in AbbVie Inc. $ABBV - Daily Political
AbbVie Links U.S. Investment Pledge And Pricing Shift To Cancer Pipeline
AbbVie (NYSE:ABBV) Trading 1.2% Higher - What's Next? - Daily Political
Townsquare Capital LLC Sells 7,540 Shares of AbbVie Inc. $ABBV
Banyan Capital Management Inc. Takes Position in AbbVie Inc. $ABBV - Markets Daily
Alpha Cubed Investments LLC Raises Stock Position in AbbVie Inc. $ABBV
Banyan Capital Management Inc. Takes Position in AbbVie Inc. $ABBV - Stock Observer
Citigroup Cuts AbbVie (NYSE:ABBV) Price Target to $230.00 - Daily Political
AbbVie's US Pricing Deal Reframes Growth Prospects And R&D Commitments - Simply Wall St News
TD Waterhouse Canada Inc. Has $26.55 Million Stock Position in AbbVie Inc. $ABBV - Markets Daily
Great Lakes Advisors LLC Decreases Stock Holdings in AbbVie Inc. $ABBV
AE Wealth Management LLC Acquires 18,651 Shares of AbbVie Inc. $ABBV
New York State Common Retirement Fund Sells 129,300 Shares of AbbVie Inc. $ABBV - Daily Political
AbbVie Inc. $ABBV Stock Holdings Lifted by Fidelis Capital Partners LLC - Stock Observer
Novo Nordisk's Massive Advertising Spend on Wegovy and Ozempic Surpasses Eli Lilly's by 2x in 2025, ETPharma
Why AbbVie Stock Trounced the Market in 2025
AbbVie (NYSE:ABBV) Stock Price Down 2.2% on Analyst Downgrade
Is AbbVie (ABBV) Pricing Reflect Its DCF And Price To Sales Signals After Recent Gains
AbbVie's Irish operations in firing line as Trump targets Botox prices
AbbVie Inc. $ABBV Shares Bought by Mirae Asset Global Investments Co. Ltd.
AbbVie (NYSE:ABBV) Shares Down 2.2% on Analyst Downgrade - Daily Political
AbbVie News
Gold price forecast: XAU/USD is above $4,900, is gold market expected to rise?
AI stocks and investment opportunities: What are the best ai stocks to invest in?
Bitcoin price prediction: Will bitcoin outperform stocks and gold in 2026?
